GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BCWorldPharm Co 200780.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

2,845

+3.08%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About BCWorldPharm Co

Its shares trade on KOSDAQ under the ticker 200780.KQ. It has been listed since 15 December 2014. In the fiscal year to 31 December 2025, it reported revenue of ₩75.80bn and a net loss of ₩4.90bn. At that date it held total assets of ₩176.80bn and shareholders' equity of ₩71.28bn.

BCWORLD PHARM.Co., Ltd. engages in the manufacture and development of pharmaceutical products. The company is headquartered in Yeoju, Gyeonggi-Do. The company went IPO on 2014-12-15. The firm's products include anesthetic pain medication such as cancer pain treatment, muscle relaxants, anesthesia and pain relief drugs; circulation contracts such as hypertension and hyperlipidemia; antibiotics such as tuberculosis treatment; other prescription drugs such as peptic ulcer and osteoporosis. In addition, the Company develops improved drugs and new products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
15 Dec 2014
Website
bcwp.co.kr ↗

Leadership

Pay as last reported

  • Yeong Gi HongChief Operating Officer, Director, since 2022
  • Seong Gyu ChiNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • BCWorldPharm manufactures anesthetic pain medication for cancer pain treatment and muscle relaxants.
  • The firm produces circulation contracts for hypertension and hyperlipidemia management.
  • BCWorldPharm develops improved drugs and new products in the pharmaceutical sector.

Weaknesses

  • The company is headquartered in Yeoju, Gyeonggi-Do, which may limit local talent access.
  • BCWorldPharm listed on the market on 15 December 2014, indicating a relatively short public history.
  • The firm focuses on prescription drugs like peptic ulcer and osteoporosis treatments.

Opportunities

  • BCWorldPharm can expand its antibiotic portfolio for tuberculosis treatment globally.
  • The company may grow its muscle relaxant sales in emerging markets.
  • BCWorldPharm can develop new anesthesia and pain relief drugs for hospitals.

Threats

  • Intense competition exists in the cancer pain treatment pharmaceutical segment.
  • Regulatory changes may impact the production of circulation contracts for hypertension.
  • BCWorldPharm faces risks from generic versions of its osteoporosis drugs.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.